U.S. Physical Therapy, Inc. (NYSE:USPH) Shares Acquired by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP boosted its position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 355.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 26,413 shares of the company's stock after purchasing an additional 20,609 shares during the period. ExodusPoint Capital Management LP owned approximately 0.17% of U.S. Physical Therapy worth $2,343,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. CBIZ Investment Advisory Services LLC increased its stake in U.S. Physical Therapy by 59.8% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after buying an additional 122 shares during the period. Venturi Wealth Management LLC increased its position in shares of U.S. Physical Therapy by 3,200.0% during the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after acquiring an additional 704 shares during the period. Pacer Advisors Inc. bought a new stake in shares of U.S. Physical Therapy during the fourth quarter valued at approximately $113,000. Mutual of America Capital Management LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $203,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its stake in U.S. Physical Therapy by 57.1% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock worth $223,000 after purchasing an additional 956 shares in the last quarter.

Remove Ads

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $82.11, for a total transaction of $142,050.30. Following the sale, the chief operating officer now owns 7,168 shares of the company's stock, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is currently owned by corporate insiders.

U.S. Physical Therapy Stock Up 0.7 %

U.S. Physical Therapy stock traded up $0.49 during trading hours on Friday, reaching $69.27. The stock had a trading volume of 164,300 shares, compared to its average volume of 105,592. U.S. Physical Therapy, Inc. has a 52 week low of $62.77 and a 52 week high of $108.14. The company has a market cap of $1.05 billion, a price-to-earnings ratio of 73.69, a PEG ratio of 3.54 and a beta of 1.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. The business's 50 day moving average price is $78.33 and its 200-day moving average price is $85.31.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The firm had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. Sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 14th were given a $0.45 dividend. This is a boost from U.S. Physical Therapy's previous quarterly dividend of $0.44. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.60%. U.S. Physical Therapy's dividend payout ratio (DPR) is presently 97.83%.

Analysts Set New Price Targets

A number of brokerages have weighed in on USPH. StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research report on Wednesday. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They set an "outperform" rating and a $113.00 target price on the stock. Barrington Research reduced their price target on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Finally, Bank of America raised shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and upped their price target for the stock from $100.00 to $115.00 in a research report on Monday, December 16th. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus target price of $109.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.